Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Alamar Biosciences, Inc.

News headline image
Alamar Biosciences Reports Second Quarter 2026 Financial Results and Provides 2026 Revenue Guidance
From Alamar Biosciences, Inc.
Via GlobeNewswire
Tickers ALMR
News headline image
Alamar Biosciences Expands Global Partnership with Alzheimer’s Disease Data Initiative and Gates Ventures
From Alamar Biosciences, Inc.
Via GlobeNewswire
Tickers ALMR
News headline image
Alamar Biosciences Launches NULISAseq™ Immune 340 Panel for Comprehensive Profiling of the Immune Proteome
From Alamar Biosciences, Inc.
Via GlobeNewswire
Tickers ALMR
News headline image
Alamar Biosciences to Report Second Quarter 2026 Financial Results on August 10, 2026
From Alamar Biosciences, Inc.
Via GlobeNewswire
Tickers ALMR
News headline image
Alamar Biosciences Partners with Leading Research Universities to Launch National Initiative Advancing Blood-Based Biomarkers for Neurodegenerative Diseases
From Alamar Biosciences, Inc.
Via GlobeNewswire
Tickers ALMR
News headline image
Alamar Biosciences NULISA Data Featured in More Than 140 Scientific Presentations at AAIC 2026, Highlighting Advances in Blood-Based Alzheimer’s Biomarker Profiling
From Alamar Biosciences, Inc.
Via GlobeNewswire
News headline image
Alamar Biosciences Launches the First Multiplexed Blood-based Immunoassay for eMTBR-Tau, One of the Most Important Biomarkers in Alzheimer’s Disease Research
From Alamar Biosciences, Inc.
Via GlobeNewswire
News headline image
Alamar Biosciences Makes Home-Collected Fingerstick Samples Compatible with Ultra High-Sensitivity, Multiplex Proteomics
From Alamar Biosciences, Inc.
Via GlobeNewswire
News headline image
Alamar Biosciences Reports First Quarter 2026 Financial Results
From Alamar Biosciences, Inc.
Via GlobeNewswire
Tickers ALMR
News headline image
Alamar Biosciences to Participate in BofA Securities 2026 Healthcare Conference
From Alamar Biosciences, Inc.
Via GlobeNewswire
Tickers ALMR
News headline image
Alamar Biosciences to Report First Quarter 2026 Financial Results on May 8, 2026
From Alamar Biosciences, Inc.
Via GlobeNewswire
News headline image
Alamar Biosciences Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
From Alamar Biosciences, Inc.
Via GlobeNewswire
News headline image
Alamar Biosciences Announces Pricing of Upsized Initial Public Offering
From Alamar Biosciences, Inc.
Via GlobeNewswire
News headline image
Alamar Biosciences Launches NULISAseq™ Neuro 220 Panel, its largest precision proteomics panel with the sensitivity and specificity to advance neurological disease research
From Alamar Biosciences, Inc.
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.